NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...
Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...
A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...
Nearly 30,000 people in England living with chronic obstructive pulmonary disease could see their lives transformed after the ...
NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...
Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...
Hosted on MSN
First Asthma Attack & COPD Treatment Breakthrough In 50 Years, Reveals A Lancet Study; Here's All You Need To Know
A new treatment is giving hope to people suffering from Chronic Obstructive Pulmonary Disease (COPD). Geoffrey Pointing, a 77-year-old from Banbury, UK, shared his experience after receiving the ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results